Skip to content

Sputum signatures for invasive pulmonary aspergillosis in patients with underlying respiratory diseases (SPARED)

Sputum signatures for invasive pulmonary aspergillosis in patients with underlying respiratory diseases (SPARED)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DPD-16009070
Enrollment
Unknown
Registered
2016-08-24
Start date
2016-08-17
Completion date
Unknown
Last updated
2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

invasive pulmonary aspergillosis (IPA)

Interventions

Gold Standard:Diagnostic criteria for IPA is based on the 2008 EORTC/MSG framework and necessary modifications are made: 1.URD is added as a host factor
2.Less-circumscribed infiltrate is added as a radiological criterion and is temporally related to current episode. Patients are classified as proven, probable or no IPA.
Index test:1.&#32
GM&#32
test
&#32
2.&#32
JF5&#32
by&#32
flow&#32
device
rtPCR

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Willing to be investigated and sign informed consent; 2. Patients with underlying respiratory diseases; 3. To be able to tolerate sputum induction.

Exclusion criteria

Exclusion criteria: 1. Patients suffering haematological malignancies; 2. A history of hematopoietic stem cell transplantation or solid-organ transplantation; 3. Failure to obtain sputum samples.

Design outcomes

Primary

MeasureTime frame
sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, diagnostic odds ratio;

Secondary

MeasureTime frame
mortality and days of hospital stay;

Countries

China

Contacts

Public ContactJuanjuan Fu

West China Hospital, Sichuan University

fu.juanjuan@scu.edu.cn+86 18980606822

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 24, 2026